This is not the most recent version of the article. View current version (21 NOV 2014)

Intervention Review

You have free access to this content

Amantadine and rimantadine for influenza A in children and the elderly

  1. Márcia G Alves Galvão2,
  2. Marilene Augusta Rocha Crispino Santos2,
  3. Antonio JL Alves da Cunha1,*

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 3 NOV 2007

DOI: 10.1002/14651858.CD002745.pub2


How to Cite

Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJL. Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD002745. DOI: 10.1002/14651858.CD002745.pub2.

Author Information

  1. 1

    Instituto de Puericultura e Pediatria Martagao Gesteria - IPPMG, Federal University of Rio de Janeiro, Departamento de Pediatria da Faculdade de Medicina, Rio de Janeiro, RJ, Brazil

  2. 2

    Municipal Secretariat of Health, Rio de Janeiro, RJ, Brazil

*Antonio JL Alves da Cunha, Departamento de Pediatria da Faculdade de Medicina, Instituto de Puericultura e Pediatria Martagao Gesteria - IPPMG, Federal University of Rio de Janeiro, Av Brig Trompowsky s/n, Cidade Universitaria - Ilha do Fundao, Rio de Janeiro, RJ, 21 940 - 590, Brazil. antonioledo@yahoo.com.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

This is not the most recent version of the article. View current version (21 NOV 2014)

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Clover 1986b {published data only}
  • Clover RD, Crawford SA, Abell TD, Ramsey CN Jr, Glezen WP, Couch RB. Effectiveness of rimantadine prophylaxis of children within families. American Journal of Diseases of Children 1986;140(7):706-9. [: CN-00043175]
Clover 1991 {published data only}
Crawford 1988 {published data only}
Finklea 1967 {published data only}
  • Finklea JF, Hennessy AV, Davenport FM. A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness. American Journal of Epidemiology 1967;85:403-12. [: 5337715]
Gravenstein 2005 {published data only}
  • Gravenstein S, Drinka P, Osterweil D, Schilling M, Krause P, Elliot M, et al. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. Journal of the American Medical Directors Association 2005;6:359-66.
Hall 1987 {published data only}
  • Hall CB, Dolin R, Gala CL, Markovitz DM, Zhang YQ, Madore PH, et al. Children with influenza A infeccion: treatment with rimantadine. Pediatrics 1987;80:275-82. [: CN-00049308]
Kitamoto 1968 {published data only}
  • Kitamoto O. Therapeutic effectiveness of amantadine hydrochloride in influenza A2-double-blind studies. The Japanese Journal of Tuberculosis and Chest Diseases 1968;15(1):17-26. [: CN-00004214]
Kitamoto 1971 {published data only}
  • Kitamoto O. Therapeutic effectiveness of amantadine hydrochloride in naturally occuring Hong Kong influenza - double-blind studies. The Japanese Journal of Tuberculosis and Chest Diseases 1971;17(1):1-7. [: CN-0000725]
Monto 1995 {published data only}
  • Monto AS, Ohmit SE, Hornbuckle K, Pearce CL. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes. Antimicrobial Agents and Chemotherapy 1995;39:2224-8. [: CN-00121619]
Patriarca 1984 {published data only}
  • Patriarca PA, Kater NA, Kendal AP, Bregman DJ, Smith JD, Sikes RK. Safety of prolonged administration of rimantadine hydrochloride in prophylaxis of influenza A virus infections in nursing homes. Antimicrobial Agents and Chemotherapy 1984;26(1):101-3. [: CN-00035517]
Payler 1984 {published data only}
Schilling 1998 {published data only}
  • Schilling M, Polvinelli L, Krause P, Gravenstein M, Ambrozaitis A, Jones HH, et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 1998;16:1771-4. [: 9778755]

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
AAPCID 2007 {published data only}
Allen 2006 {published data only}
  • Allen UD, Aoki FY, Stiver HG. The use of antiviral drugs for influenza: recommended guidelines for practioners. The Canadian Journal of infectious Diseases and Medical Microbiology 2006;17(5):273-84.
Anonymous 2006 {published data only}
  • Anonymous. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire International 2006;15(81):21-30.
Anonymous 2007 {published data only}
  • Anonymous. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best. Prescrire International 2007;16(87):9-11.
Aoky 1985a {published data only}
Aoky 1985b {published data only}
  • Aoky FY, Silver HG, Sitar DS, Boudreault A, Ogilvie RI. Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults. Clinical Pharmacology and Therapeutics 1985;37(2):128-36. [: CN-00036657]
Aoky 1986 {published data only}
  • Aoky FY, Sitar DS, Milley EV. Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian Forces personnel 1980-1983. Military Medicine 1986;151(9):459-65. [: CN-00174577]
Atmar 1990 {published data only}
  • Atmar RL, Greenberg SB, Quarles JM, Wilson SZ, Tyler B, Feldman S, et al. Safety and pharmacokinetics of rimantadine small-particle aerosol. Antimicrobial agents and chemotherapy 1990;34(11):2228-33. [: CN-00073727]
Baker 1969 {published data only}
  • Baker LM, Shock MP, Iezzoni DG. The therapeutic efficacy of Symmetrel (amantadine hydrochloride) in naturally occuring influenza A2 respiratory illness. The Journal of the American Osteopathic Association 1969;68(12):1244-50. [: CN-00003808]
Barr 2007 {published data only}
  • Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C, Komadina N. The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006. Antiviral Research 2007;75(2):173-6.
Barr 2007b {published data only}
  • Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N, Komadina N. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Research 2007;73(2):112-7.
Bauer 2007 {published data only}
  • Bauer K, Schrader C, Suess J, Wutzler P, Schmidtke M. Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999. Antiviral Research 2007;75(3):219-26.
Belenky 1998 {published data only}
  • Belenky S, Gentile D, Doyle W, Patel A, Hayden F, Skoner D. Rimantadine effect on specific serum hemagglutination inhibition and nasal antibodies in experimental influenza virus exposure of adults. American Journal of Respiratory and Critical Care Medicine 1998;157(3):A173. [: CN-00428220]
Bloomfield 1970 {published data only}
  • Bloomfield SS, Gaffney TE, Schiff GM. A design for the evaluation of antiviral drugs in human influenza. American Journal of Epidemiology 1970;91(6):568-74. [: CN-00004457]
Brady 1990 {published data only}
  • Brady MT, Sears SD, Pacini DL, Samorodin R, DePamphilis J, Oakes M, et al. Safety and prophylatic efficacy of low-dose rimantadine in adults during an influenza A epidemic. Antimicrobial Agents and Chemotherapy 1990;34(9):1633-6. [: CN-00073150]
Bricaire 1990 {published data only}
  • Bricaire F, Hannoun C, Boissel JP. Prevention of influenza A. Effectiveness and tolerance of rimantadine hydrochloride [Prevention de la grippe A. Efficacite et tolerance du chlohydrate de rimantadine]. Nouvelle Presse Médicale 1990;19(2):69-72. [: CN-00065369]
Bryson 1990 {published data only}
  • Bryson YJ, Monahan C, Pollack M, Shields WD. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. The Journal of Infectious Diseases 1980;141:543-7. [: CN-00022658]
Callmander 1968 {published data only}
  • Callmander E, Hellgren L. Amantadine hydrochloride as a prophylatic in respiratoty infections. A double-blind investigation of its clinical use and serology. The Journal of Clinical Pharmacology and The Journal of New Drugs 1968;8(3):186-9.
Chemaly 2006 {published data only}
  • Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ el al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006;85(5):278-87.
Cheng 2004 {published data only}
Cohen 1976 {published data only}
  • Cohen A, Togo Y, Khakoo R, Waldman R, Sigel M. Comparative clinical and laboratory evaluation of the prophylatic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A. The Journal of Infectious Diseases 1976;133(Suppl):A114-20. [: CN-0014092]
Cohen 2006 {published data only}
  • Cohen J, Cairns C, Paquette C, Faden L. Compairing patient access to pharmaceuticals in the UK and US. Applied Health Economics and Health Policy 2006;5(3):177-87.
Dawkins 1968 {published data only}
  • Dawkins AT Jr, Gallager LR, Togo Y, Hornick RB, Harris BA. Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analoge of amantadine hydrochloride. Journal of the American Medical Association 1968;203:1095-9. [: CN-00001969]
Denys 1963 {published data only}
  • Denys A, Szram S, Tkaczewski W, Niedzielska H, Bochenska J, Kulawczyk M, et al. Antiviral activity of rimantadine, virological, pathomorphological, and clinical studies. Acta Microbiologica Polonica. Series A: Microbiologia Generalis 1973;5:217-20. [: CN-00009559]
Dolamore 2003 {published data only}
  • Dolamore MJ. Influenza prophylaxis in long-tern care facility: a case-control study of the risk factors for adverse drug reactions to amantadine. Current Therapeutic Research, Clinical and Experimental 2003;64(9):753. [MEDLINE: 2004048279]
Dolin 1982 {published data only}
  • Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. The New England Journal of Medicine 1982;307(10):580-4. [: CN-00201667]
Doyle 1998 {published data only}
  • Doyle WJ, Skoner DP, Patel A, Hayden FG. Effect of rimantadine on induced specific serum haemagglutination-inhibiting antibody and nasal IgA titres after experimental exposure of adults to influenza A virus. Antiviral Therapy 1998;3(1):19-23. [: CN-00201667]
Drinevskii 1998 {published data only}
  • Drinevskii VP, Osidak LV, Natsina VK, Afanas'eva OI, Mil'kint KK, Danini GV, et al. Chemotherapeutics for treatment of influenza and other viral respiratory tract infections in children [Khimiopreparaty v terapii grippa i drugikh respiratomykh infektsii u detei]. Antibiotiki i Khimioterapiia 1998;43(9):29-34. [: CN-00332458]
Drinka 1998 {published data only}
  • Drinka PJ, Gravenstein S, Schilling M, Krause P, Miller BA, Shult P. Duration of antiviral prophylaxis during nursing home outbreaks of influenza. A comparison of 2 protocols. Archives of Internal Medicicine 1998;158(19):2155-9. [: CN-00156407]
Enger 2004 {published data only}
Furuta 2005 {published data only}
Galabov 2006 {published data only}
  • Galabov AS, Simeonova L, Gegova G. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice. Antiviral Chemistry & Chemotherapy 2006;17(5):251-8.
Galbraith 1969a {published data only}
  • Galbraith AW, Oxford JS, Schild GC, Watson GI. Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet 1969;2(7629):1026-8. [: CN-00003903]
Galbraith 1969b {published data only}
  • Galbraith AW, Oxford JS, Schild GC, Watson GI. Study of 1-adamantanamine hydrochloride used prophylatically during the Hong-Kong influenza epidemic in the family environment. Bulletin of the World Health Organization 1969;41(3):677-82. [: 00004308]
Galbraith 1971 {published data only}
  • Galbraith AW, Oxford JS, Schild GC, Potter CW, Watson GI. Therapeutic effect of 1-adamantanamine hydrochloride in naturally occuring influenza A 2-Hong Kong infection. A controlled double-blind study. Lancet 1971;2(7716):113-5. [: 00006011]
Galbraith 1973 {published data only}
  • Galbraith AW, Schild GC, Potter CW, Watson GI. The therapeutic effect of amantadine in influenza occurring during the winter of 1971-2 assessed by double-blind study. The Journal of the Royal College of General Practitioners 1973;23(126):34-7. [: CN-00008567]
Garman 2004 {published data only}
Gerth 1966 {published data only}
  • Gerth, HJ. Influenza prevention with 1-amino-adamantan-hydrochloride.II [Grippeprophylaxe mit 1-Amino-adamantan-hydrochlorid]. Die Medizinische Welt 1966;2:96-100. [: CN-00000687]
Griffin 2004 {published data only}
  • Griffin SDC, Harvey R, Clarke DS, Barclay WS, Harris M, Rowlands DJ. A conserved basic loop in hepatites C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. The Journal of General Virology 2004;85(2):451-61. [MEDLINE: 2004096848]
Hay 1986 {published data only}
  • Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH. Molecular basis of resistance of influenza A viruses to amantadine. The Journal of Antimicrobial Chemotherapy 1986;18:19-29. [: 00341317]
Hayden 1979 {published data only}
  • Hayden FG, Hall WJ, Douglas RGJ, Speers DM. Amantadine aerosols in normal volunteers; pharmacology and safety testing. Antimicrobial Agents and Chemotherapy 1979;16(5):644-50. [: CN-00341319]
Hayden 1980 {published data only}
  • Hayden FG, Hall WJ, Douglas FG Jr. Therapeutic effects of aerolized amantadine in naturally acquired infection due to influenza A virus. The Journal of Infectious Diseases 1980;141(5):535-42. [: CN-00022657]
Hayden 1981 {published data only}
  • Hayden FG, Gwaltney JM Jr, Van de Castle RL, Adams KF, Giordani F. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrobial Agents and Chemotherapy 1981;19(2):226-33. [: CN-00029040]
Hayden 1982 {published data only}
  • Hayden FG, Zylidnikov DM, Iljenko VI, Padolka YV. Comparative therapeutic effect of aerolized and oral rimantadine HCl in experimental human influenza A virus infection. Antiviral Research 1982;2(3):147-53. [: CN-00029306]
Hayden 1985 {published data only}
  • Hayden FG, Minocha A, Spyker DA, Hoffman HE. Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrobial Agents and Chemotherapy 1985;28(2):216-21. [: CN-00341320]
Hayden 1986 {published data only}
Hayden 1989 {published data only}
  • Hayden FG, Belshe RB, Clover RB, Hay AJ, Oakes MG, Soo W. Emergence and and aparent transmission of rimantadine-resistant influenza A virus in families. The New England Journal of Medicine 1989;321(25):1696-702. [: CN-00064208]
Hayden 1991 {published data only}
  • Hayden FG, Sperber SJ, Belshe RB, Clover RD, Hay AJ, Pyke S. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrobial Agents and Chemotherapy 1991;35:1741-7. [: CN-00079594]
Hayden 2000 {published data only}
  • Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliott MJ, Hammond JM, et al. Inhaled zanamivir for the prevention of influenza in families. The New England Journal of Medicine 2000;343(18):1282-9. [: CN-00399563]
Hayden 2006 {published data only}
  • Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. The Journal of Infectious Diseases 2006;194(Suppl 2):155-61.
Hornick 1969 {published data only}
  • Hornick RB, Togo Y, Mahler S, Iezzoni D. Evaluation of amantadine hydrochloride in the treatment of A2 influenzal disease. Bulletin of the World Health Organization 1969;41(3):671-6. [: CN-00004307]
Hout 2006 {published data only}
  • Hout DR, Gomez LM, Pacyniak E, Miller JM, Hill MS, Stephens EB. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine. Virology 2006;348(2):449-61.
Hout 2006b {published data only}
  • Hout DR, Gomez ML, Pacyniak E, Gomez LM, Fegley B, Mulcahy ER el al. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques. Virology 2006;344(2):541-59.
Hurt 2007 {published data only}
  • Hurt AC, Selleck P, Komadina S, Shaw R, Brown L, Barr IG. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Research 2007;73(3):228-31.
Ilyushina 2005 {published data only}
Ilyushina 2006 {published data only}
  • IIyushina NA, Bovin NV, Webster RG, Govorkova EA. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral Research 2006;70(3):121-31.
Ilyushina 2007 {published data only}
  • Ilyushina NA, Gorkova EA, Russell CJ, Hoffmann E, Webster RG. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. The Journal of General Virology 2007;88(4):1266-74.
Ilyushina 2007b {published data only}
  • Ilyushina NA, Hoffmann E, Solomon R, Webster RG, Govorkova EA. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antiviral Therapy 2007;12(3):363-70.
Ison 2006 {published data only}
  • Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. The Journal of Infectious Diseases 2006;193(6):760-4.
Ito 2000 {published data only}
  • Ito S, Iijima N, Kanemaki K, Hayashi S, Hujii S, Watanabe T, et al. Therapeutic efficacy of amantadine hydrochloride in patients with epidemic influenza A virus infection. Nihon Kokyuki Gakkai Zasshi [The journal of the Japanese Respiratory Society] 2000;38(12):897-902. [: CN: 00327106]
Ito 2006 {published data only}
  • Ito Y, Sumi H, Kato T. Evaluation of influenza vaccination in health care workers, using rapid antigen detection test. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 2006;12(2):70-2.
Jefferson 2004 {published data only}
  • Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in in adults. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD001169.pub3; PUBMED: PMID: 12137620]
Jefferson 2006a {published data only}
Jones 2006 {published data only}
  • Jones JC, Turpin EA, Bultmann H, Brandt CR, Schultz-Cherry S. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. Journal of Virology 2006;80(24):11960-7.
Kantor 1980 {published data only}
  • Kantor RJ, Stevens D, Potts DW, Noble GR. Prevention of influenza A/USSR/77 (H1N1): an evaluation of the side effects and efficacy of amantadine in recruits at Fort Sam Houston. Military Medicine 1980;145(5):312-5. [: CN-00176323]
Kawai 2005 {published data only}
  • Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Maeda T, et al. Factors influencing the effects of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 2005;40:1309-16.
Khakoo 1981 {published data only}
  • Khakoo RA, Watson GW, Waldman RH, Ganguly R. Effect of inosiplex (Isoprinosine (Reg. trademark)) on induced human influenza A infection. The Journal of Antimicrobial Chemotherapy 1981;7(4):389-97. [: CN-00192285]
Kiso 2004 {published data only}
Kitamoto 1969 {published data only}
  • Kitamoto O. Early diagnosis and treatment of influenza. Naika. Internal medicine 1969;23(6):1271-6. [: CN-00003590]
Knight 1969 {published data only}
  • Knight V, Fedson D, Baldini J, Douglas RG, Couch RB. Amantadine therapy of epidemic influenza A2-Hong Kong. Antimicrobial Agents and Chemotherapy 1969;9:370-1. [: CN-00320019]
Knight 1970a {published data only}
  • Knight V, Fedson D, Baldini J, Douglas R, Couch R. Amantadine therapy of epidemic influenza A (Hong Kong). Infection and Immunity 1970;1:200-4. [: 00203595]
Knight 1970b {published data only}
  • Knight V, Fedson D, Baldini J, Douglas R, Couch R. Amantadine therapy of epidemic influenza A (Hong Kong). Infection and Immunity 1970;1:200-4.
Knight 1981 {published data only}
Krylov 1978 {published data only}
  • Krylov VF, Ketilladze ES, Smagulova EG, Alekseeva AA, Nefelova MM. Use of rimantadine in familial foci during an epidemic of influenza caused by A1 virus [Primenenie rimantadina v semeinykh ochagakh v period epidemii grippa, vyzvannogo virusom A1]. Voprosy Virusologii 1978;3:277-82. [: CN-00018933]
Kulichenko 2003 {published data only}
  • Kulichenko LL, Kireyeva LV, Malyshikina EN, Wikman G. A randomized controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd. Journal of Erbal Pharmacotherapy 2003;3(1):77-93. [: CN-00473824]
Le Tissier 2005 {published data only}
  • Le Tissier PR, Carmignac DF, Lilley S, Sesay AK, Phelps CJ, Houston P, et al. Hypothalamic growth hormone-releasing hormone (GHRH) defiency: target ablation pf GHRH neurons in mice using a viral ion channel transgene. Molecular Endocrinology 2005;19(5):1251-62.
Leeming 1969 {published data only}
Leone 2005 {published data only}
Leung 1979 {published data only}
  • Leung P, McIntosh K, Chai H. Amantadine prophylaxis against influenza A/USSR in children with chronic asthma. The Journal of Allergy and Clinical Immunology 1979;63(3):140. [: CN-00353210]
Lim 2007 {published data only}
Lin 2006 {published data only}
  • Lin CH, Huang YC, Chi CH, Huang CG, Tsao KC, Lin TY. Neurologic manifestations in children with influenza B virus infection. The Pediatric Infectious Disease Journal 2006;25(11):1081-3.
Linder 2005 {published data only}
Lipatov 2007 {published data only}
  • Lipatov AS, Evseenko VA, Yen HL, Zaykovskaya AV, Durimanov AG, Zolotykh SI, et al. Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006. Emerging Infectious Diseases 2007;13(4):539-46.
Little 1976 {published data only}
  • Little JW, Hall WJ, Douglas RG Jr, Hyde RW, Speers DM. Amantadine effect on peripheral airways abnormalities in influenza A study in 15 students with natural influenza A infection. Annals of Internal Medicine 1976;85(2):177-82. [: CN-00014385]
Little 1978 {published data only}
  • Little JW, Hall WJ, Douglas RG Jr, Mudholkar GS, Speer DM, Patel K. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. The American Review of Respiratory Disease 1978;118(2):295-303. [: CN-00018956]
Lutz 2005 {published data only}
  • Lutz A, Dyall J, Olivo PD, Pekosz A. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. Journal of Virological Methods 2005;126(1-2):13-20.
Lynd 2005 {published data only}
Machado 2004 {published data only}
Mallia 2007 {published data only}
  • Mallia P, Johnston SL. Influenza infection and COPD. International Journal of Chronic Obstructive Pulmonary Disease 2007;2(1):55-64.
Maricich 2004 {published data only}
  • Maricich SM, Neul JL, Lotze TE, Cazacu AC, Uyeki TM, Demmler GJ, et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics 2004;114(5):626-33.
Mase 2007 {published data only}
  • Mase M, Eto M, Imai K, Tsukamoto K, Yamaguchi S. Caracterization of H9N2 influenza A viruses isolated from chicken products imported into Japan from China. Epidemiology and Infection 2007;135(3):386-91.
Mate 1970 {published data only}
  • Mate J, Simon M, Juvancz I, Takatsy G, Hollos I, Farkas E. Prophylatic use of amantadine during Hong Kong influenza epidemic. Acta Microbiologica Academiae Scientiarum Hungaricae 1970;17(3):285-96.
Mate 1971 {published data only}
  • Mate J, Simon M, Juvancz I. Use of Viregyt (amantadine hydrochloride) in the treatment of epidemic influenza. Therapia Hungarica 1971;19(3):117-21. [: CN-00006813]
Matsuya 2007 {published data only}
  • Matsuya Y, Sasaki K, Ochiai H, Nemoto H. Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic. Bioorganic & Medicinal Chemistry 2007;15(1):424-32.
Matthews 2004 {published data only}
McCullers 2004 {published data only}
McKay 2006 {published data only}
Mishin 2005 {published data only}
Monto 1979 {published data only}
Muldoon 1976 {published data only}
  • Muldoon RL, Stanley ED, Jackson GG. Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A. The American Review of Respiratory Disease 1976;113:487-91. [: CN-00203757]
Nafta 1970 {published data only}
  • Nafta I, TTurcanu AG, Braun I, Companetz W, Simionescu A. Administration of amantadine for the prevention of Hong-Kong influenza. Bulletin of the World Health Organization 1970;42(3):200-4. [: CN-00004499]
Natsina 1994 {published data only}
  • Natsina VK, Drinevskii VP, Milkint KK. Remantadine in the treatment of influenza in children [Primenenie remantadina dlia lecheniia grippa u detei]. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk Vestnik 1994;9:51-5. [: CN-00110913]
O'Donoghute 1973 {published data only}
  • O'Donoghute JM, Ray CG, Terry DW Jr, Beaty HN. Prevention of nosomial influenza infection with amantadine. American Journal of Epidemiology. 1973;97(4):276-82. [: CN-00008489]
Obrosova-Serova 1972 {published data only}
  • Obrosova-Serova NP, Fedorova GI, Glukhov PI, Shal'nov MI, Litvinov VG. Effectiveness of midantan and interferon inducers as means og non-specific prevention of influenza [Izuchenie effektivnosti midantana i stimuliatorav interferona kak sredstv nespetsificheskoi profilaktiki grippa]. Antibiotiki 1972;17:734-8. [: CN-00007887]
Oker-Blom 1970 {published data only}
  • Oker-Blom N, Hovi T, Leinikki P, Palosuo T, Petterson R, Suni J. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. British Medical Journal 1970;3(724):676-8. [: CN-00004991]
Ong 2007 {published data only}
Pachucki 2004 {published data only}
  • Pachucki CT, Kurshid MA, Nawrocki J. Utility of reverse transcriptase PCR for rapid diagnosis of influenza A virus infection and detection of amantadine-resistant influenza A virus isolates. Journal of Clinical Microbiology 2004;42(6):2796-8. [MEDLINE: 2004251487]
Peiris 2004 {published data only}
Pemberton 1986 {published data only}
  • Pemberton RM, Jennings R, Potter CW, Oxford JS. Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates. The Journal of Antimicrobial Chemotherapy 1986;18:135-40. [: CN-00341484]
Petterson 1980 {published data only}
  • Petterson RF, Hellstrom PE, Penttinen K, Pyhala R, Tokola O, Vartio T, et al. Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients. The Journal of Infectious Diseases 1980;142(3):377-83. [: CN-00023981]
Pritchard 1989 {published data only}
Quarles 1981 {published data only}
Quilligan 1966 {published data only}
  • Quilligan JJ Jr, Hirayama H, Baernstein HD Jr. The suppression of A2 influenza in children by the chemoprophylatic use of amantadine. The Journal of Pediatrics 1966;69(4):572-5. [: CN-00000801]
Rabinovich 1969 {published data only}
  • Rabinovich S, Baldini JT, Bannister R. Treatment of influenza. The therapeutic efficacy of rimantadine HCl in a naturally occurring influenza A2 outbreak. The American Journal of the Medical Sciences 1969;257(5):328-35. [: CN-00003292]
Reis 2006 {published data only}
  • Reis J, John D, Heimeroth A, Mueller HH, Oertel WH, Arndt T, et al. Modulation of human motor cortex excitability by single doses of amantadine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 2006;31(12):2758-66.
Reuman 1989a {published data only}
Reuman 1989b {published data only}
  • Reuman PD, Bernstein DI, Keefer MC, Young EC, Sherwood JR, Schiff GM. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Research 1989;11(1):27-40. [: CN-00059636]
Risebrough 2005 {published data only}
Rose 1980 {published data only}
  • Rose HJ. Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus. The Journal of Infectious Diseases 1980;141(5):535-42. [: CN-00022657]
Rothberg 2005 {published data only}
Saito 2006 {published data only}
  • Saito R, Li D, Shimomura C, Masaki H, Le MR, Nquyen HL, et al. An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan. The Tohoku Journal of Experimental Medicine 2006;210(1):21-7.
Sauerbrei 2006 {published data only}
  • Sauerbrei A, Haertl A, Brandstaedt A, Schmidtke M, Wutzler P. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors. Medical Microbiology and Immunology 2006;195(2):65-71.
Schapira 1971 {published data only}
  • Schapira M, Oxford JS, Galbraith AW. Therapeutic effect of 1-adamantanamine hydrochloride in naturally. Journal of the Royal College of General Practitioners 1971;21(113):695-7. [: CN-00006890]
Schmidt 2004 {published data only}
Sears 1987 {published data only}
  • Sears SD, Clements ML. Protective efficacy of low dose amantadine in adults challenge with wild-type influenza A virus. Antimicrobial Agents and Chemotherapy 1987;31(10):1470-3. [: CN-00052243]
Semlitsch 1992 {published data only}
  • Semlitsch HV, Anderer P, Saletu B. Topographic mapping of long latency "cognitive"event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia. Journal of Neural Transmission. Parkinson's disease and dementia section 1992;4:319-36. [: CN-00087210]
Serkedjieva 2007 {published data only}
  • Serkedjieva J, Toshkova R, Antonova-Nikolova S, Stefanova T, Teodosieva A, Ivanova I. Effect of a plant polyphenol-rich extract on the lung protease activities of influenza-virus-infected mice. Antiviral Chemistry & Chemotherapy 2007;18(2):75-82.
Shuler 2007 {published data only}
  • Schuler CM, Iwamoto M, Bridges CB, Marin M, Neeman R, Gargiullo P, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 2007;119(3):587-95.
Shvetsova 1974 {published data only}
  • Shvetsova EG, Malysheva AM, Karapats NM, Oleinikova EV, Vasil'eva RI. Comparative study of the epidemiological efficacy of specific and nonspecific influenza preventive agents [Sravnitel'noe izuchenie epidemiologicheskoi effektivnosti speisificheskikh i nespetsificheskikh sredstv profilaktiki grippa]. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii [Journal of microbiology, epidemiology and immunobiology] 1974;51(4):47-51. [: CN-00010299]
Skoner 1999 {published data only}
  • Skoner DP, Gentile DA, Patel A, Doyle WJ. Evidence for cytokine mediation of disease exression in adults experimentally infected with influenza A virus. The Journal of Infectious Diseases 1999;180(1):10-4. [: CN-00163791]
Smorodintsev 1970a {published data only}
  • Smorodintsev AA, Zlydnikov DM, Kiselva AM, Romanov JA, Kanantsev AP, Rumovsky VI. Evaluation of amatadine in artificially induced A2 and B influenza. JAMA : the journal of the American Medical Association 1970;213(9):1448-54. [: CN-00004739]
Smorodintsev 1970b {published data only}
  • Smorodintsev AA, Karpuhin GI, Zlydnikov DM, Malyseva AM, Svecova EG, Burov SA, et al. The prophylatic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969. Bulletin of the World Health Organization 1970;42(6):865-72. [: CN-00005082]
Smorodintsev 1970c {published data only}
  • Smorodintsev AA, Karpuhin GI, Zlydnikov DM. The prospect of amantadine for prevention of influenza A in humans (effectiveness of amantadine during influenza A2/Hong Kong epidemics in January-February 1969 in Leningrad. Annals of the New York Academy of Sciences 1970;173:44-73.
Somani 1991 {published data only}
  • Somani SK, Degelau J, Cooper SL, Guay DRP, Ehresman D, Zaske D. Comparision of pharmacokinetic and safety profiles of amantadine 50 and 100 mg daily doses in elderly nursing home residents. Pharmacotherapy 1991;11(6):440-66. [: CN-00441230]
Tajima 2006 {published data only}
  • Tajima T, Kakayama E, Kondo Y, Hirai F, Ito H, Iitsuka T, et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2006;12(6):372-9.
Takemura 2005 {published data only}
  • Takemura Y, Ishida H, Saitoh H, Kure H, Kakoi H, Ebisawa K, et al. Economic consequence of immediate testing for C-reactive protein and leukocyte count in new outpatients with acute infection. Clinica Chimica Acta; International Journal of Clinical Chemistry 2005;360(1-2):114-21.
Terabayashi 2006 {published data only}
  • Terabayashi T, Morita M, Ueno M, Nakamura T, Urashima T. Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates. Carbohydrate Research 341;13:2246-53.
Thompson 1987 {published data only}
Togo 1968 {published data only}
  • Togo Y, Hornick RB, Dawkins AT Jr. Studies on induced influenza in man. I. Double-blind studies designed to assess prophylatic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain. Journal of the American Medical Association 1968;203(13):1089-94. [: CN-00001827]
Togo 1970 {published data only}
  • Togo Y, Hornick RB, Felitti VJ, Kaufman ML, Dawkins AT Jr, Kilpe VE, et al. Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A2 influenza. Journal of the American Medical Association 1970;211(7):1149-56. [: CN-00004092]
Togo 1972 {published data only}
  • Togo Y, Schwatrz AR, Tominaga S, Hornick RB. Cyclooctylamine in the prevention of experimental human influenza. Journal of the American Medical Association 1972;220(6):837-41. [: CN-00007054]
Townsend 2006 {published data only}
van der Wouden 2005 {published data only}
Van Voris 1981 {published data only}
  • Van Voris LP, Betts RF, Hayden FG, Christmas WA, Douglas RG Jr. Successful treatment of naturally occuring influenza A/USSR/77 H1N1. Journal of the American Medical Association 1981;245(11):1128-31. [: CN-00024393]
Van Voris 1985 {published data only}
Webster 1986 {published data only}
  • Webster R, Kawaoka Y, Bean W. Vaccination as strategy to reduce the emergence of amantadine and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus. The Journal of Antimicrobial Chemotherapy 1986;18:157-64. [: CN-00341633]
Wendel 1966 {published data only}
Wingfield 1969 {published data only}
  • Wingfield WL, Pollack D, Grunert RR. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occuring influenza A2 respiratoty illness in man. The New England Journal of Medicine 1969;281(11):579-84.
Wong 2006 {published data only}
Wright 1976 {published data only}
  • Wright PF, Khaw KT, Oxman MN, Shwachman H. Evaluation of the safety of amantadine-HCL and the role of respiartory viral infections in children with cystic fibrosis. The Journal of Infectious Diseases 1976;134(2):144-9. [: CN-00208364]
Wultzler 2004 {published data only}
  • Wultzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, et al. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(2):84-91. [: Unique identifier: 15364262]
Yamaura 2003 {published data only}
  • Yamaura K, Yoshihara M. Investigation of the reconsultation rate and pharmacoeconomic evaluation of period of influenza treatment by oseltamivir. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2003;123(10):887-91.
Younkin 1983 {published data only}
  • Younkin SW, Betts RF, Roth FK, Douglas RG Jr. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrobial Agents and Chemotherapy 1983;23(4):577-82. [: CN-00031339]
Yuen 2005 {published data only}
  • Yuen KY, Wong SS. Human infection by avian influenza A H5N1. Hong Kong Medical Journal 2005;11(3):189-99.
Zeuzem 1999 {published data only}
  • Zeuzem S, Teuber G, Naumann U, Berg T, Raedle J, Hartmann S, et al. Randomised, double-blind, placebo-controlled trial of interferon-alfa with and without amantadine as initial treatment for chronic hepatitis C. Hepatology 1999;30(4):200A. [: CN-00271208]

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Bonn 1997
Demicheli 2000
Dolin 2005
Eccle 2005
Goodman 2006
  • Goodman C, Mukherjee D, Faulkner E. How effective would antiviral vaccination and antiviral drug prevention and treatment strategies be for reducing the impact of the next influenza pandemic. Copenhagen, WHO Regional Office for Europe (Health Evidence Network report; http://www.euro.who.int/Document/E88034.pdf (Accessed October 20, 2007) 2006.
Hayden 2004
  • Hayden FG. Pandemic influenza: is an antiviral response realistic?. Pediatric Infectious Disease Journal 2004;23(Suppl):262-9.
Hayden 2005
  • Hayden FG, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, et al. Neuraminidase inhibitor susceptibility network position statment: antiviral resistance in influenza A/H5N1 viruses. Antiviral Therapy 2005;10(8):873-7.
Hayden 2006b
Higgins 2005
  • Higgins JPT, Green S, editors. Developing and documenting a search strategy for studies and organizing search results. Cochrane Handbook for Systematic Reviews of Interventions 4.2 [updated May 2005]; Section 5. In: The Cochrane Library. Vol. Issue 3, Chichester, UK: John Wiley & Sons, Ltd, 2005.
Jadad 1996
  • Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
Jefferson 2006b
Moscona 2005
MS 2006
  • Ministério da Saúde 2006 (Brazilian Ministry of Health 2006). Human influenza and avian influenza [Influenza humana e influenza aviária]. Série F. Comunicação e Educação em Saúde 2006.
Nicholson 1992
  • Nicholson K. Clinical featuresof influenza. Seminars in Respiratory Infections 1992;7(1):26-37.
Pineda Solas 2006
  • Pineda Solas A, Bernaola Iturbe E, Martinon-Torres F, Baca Cots M, de Juan Martin F, Gomez Campdera JA, et al. Recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics: influenza vaccination campaign 2006-2007. Anales de Pediatría 2006;65(3):252-5.
Smith 2006
  • Smith NM, Bresee JJ, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2006;55(RR10):1-42. [: ISSN 1545-8601 (Electronic)]
Treanor 2005
  • Treanor JJ. Influenza Viruses. In: Mandell, Bennett, & Dolin editor(s). Principles and Practice of Infectious Diseases. 6th Edition. Vol. 2, W. B. Saunders, an imprint of Elsevier, 2005:2060-85.
WHO 2003
  • World Health Organization. Influenza. Geneva, World Health Organization, 2003 (Fact Sheet No. 211). http://www.who.int/mediacentre/factsheets/fs211/en/print.html (Accessed October 20, 2007) 2003.
WHO 2007
  • World Health Organization. Child and adolescent health and development. http://www.who.int/child-adolescent-health/over.htm (Accessed January 20, 2007).
Wiselka 1994
Wright 2004
  • Wright P. Influenza Viruses. In: Richard E Behrman, Robert M Kliegman, Hall B Jenson editor(s). Nelson Textbook of Pediatrics of Pediatrics. 17. Saunders, An Imprint of Elsevier, 2004:1072-5.